GLP-1 agonist blockbuster weight-loss drug Zepbound with its "MindBody GLP-1 System": The MindBody GLP-1 System was launched in October 2024 and targets consumers searching for an effective ...

$204.3 million consensus. "Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used together ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.